OTC Markets Group Welcomes New OTCQB Companies – December 20

 OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following company is approved for trading on the OTCQB Venture Market:

Xanthic Biopharma Inc. (CSE: GGB; OTCQB: GGBXF) The Company is a lifestyle oriented, consumer products company that celebrates health, wellness and happiness. Xanthic Biopharma is in the business of cultivation, processing and retailing of cannabis, tetrahydrocannabidol, cannabidiol and cannabis-infused consumer products. Over the next 12 months, the Company intends to expand its retail and wholesale cannabis businesses as well as its CBD consumer products business through a combination of strategic partnerships, merger and acquisition activity, and organic license capture. The Company's objectives are to establish retail cannabis locations, or otherwise apply for such licenses, in various states within that timeframe, pursuant to state laws. Such activity will focus on those certain states where cannabis has been legalized for medical and/or recreational use at the state level.

U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for this company on www.otcmarkets.com.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities.  Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit  www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

OTC Markets, OTCQX, OTCQB, Pink and OTC Link are registered trademarks of OTC Markets Group Inc.

Subscribe to the OTC Markets RSS Feed